Your browser is no longer supported. Please, upgrade your browser.
McKesson Corporation
IndexS&P 500 P/E- EPS (ttm)-27.09 Insider Own0.04% Shs Outstand159.50M Perf Week1.21%
Market Cap30.52B Forward P/E10.26 EPS next Y18.83 Insider Trans-34.46% Shs Float157.74M Perf Month3.30%
Income-4189.00M PEG- EPS next Q5.00 Inst Own88.60% Short Float1.74% Perf Quarter5.67%
Sales237.62B P/S0.13 EPS this Y15.00% Inst Trans-1.39% Short Ratio2.75 Perf Half Y25.43%
Book/sh-2.99 P/B- EPS next Y9.53% ROA-6.90% Target Price216.47 Perf Year39.87%
Cash/sh22.64 P/C8.53 EPS next 5Y10.36% ROE-104.90% 52W Range125.65 - 198.43 Perf YTD11.07%
Dividend1.68 P/FCF5.95 EPS past 5Y-8.00% ROI23.10% 52W High-2.65% Beta0.90
Dividend %0.87% Quick Ratio0.60 Sales past 5Y5.20% Gross Margin5.10% 52W Low53.74% ATR3.71
Employees80000 Current Ratio1.00 Sales Q/Q5.80% Oper. Margin-1.90% RSI (14)57.45 Volatility1.61% 1.95%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin-1.80% Rel Volume0.87 Prev Close191.37
ShortableYes LT Debt/Eq- EarningsMay 06 AMC Payout- Avg Volume1.00M Price193.18
Recom1.90 SMA200.73% SMA504.51% SMA20015.06% Volume867,977 Change0.95%
Mar-30-21Upgrade Argus Hold → Buy $230
Nov-02-20Upgrade Barclays Equal Weight → Overweight $166
Aug-04-20Upgrade Deutsche Bank Hold → Buy $202
May-22-20Upgrade Wolfe Research Peer Perform → Outperform
May-15-20Upgrade UBS Neutral → Buy $151 → $160
Apr-23-20Resumed Credit Suisse Neutral $146
Mar-18-20Upgrade Goldman Neutral → Buy $173 → $174
Mar-13-20Upgrade Guggenheim Neutral → Buy
Feb-07-20Upgrade Robert W. Baird Neutral → Outperform $197
Jan-10-20Upgrade Morgan Stanley Equal-Weight → Overweight $162
Sep-12-19Initiated Deutsche Bank Hold
Aug-05-19Downgrade Wolfe Research Outperform → Peer Perform
Jul-22-19Initiated Guggenheim Neutral $152
Jan-17-19Initiated UBS Neutral $134
Oct-26-18Reiterated Barclays Equal Weight $150 → $136
Jul-20-18Downgrade Robert W. Baird Outperform → Neutral
May-29-18Reiterated Leerink Partners Mkt Perform $170 → $160
Mar-08-18Initiated Barclays Equal Weight $165
Feb-27-18Resumed BofA/Merrill Buy
Feb-02-18Reiterated Mizuho Neutral $186 → $179
Apr-15-21 08:14AM  
Apr-13-21 12:10PM  
Apr-12-21 12:17PM  
Apr-05-21 09:49AM  
Apr-03-21 10:56AM  
Apr-01-21 04:10PM  
Mar-31-21 09:15AM  
Mar-29-21 10:08AM  
Mar-26-21 11:50AM  
Mar-22-21 07:32PM  
Mar-15-21 09:15AM  
Mar-12-21 08:03AM  
Mar-11-21 09:47AM  
Mar-10-21 09:53AM  
Mar-09-21 11:50AM  
Mar-04-21 11:30AM  
Mar-01-21 02:52PM  
Feb-18-21 07:15AM  
Feb-02-21 02:00PM  
Feb-01-21 10:55AM  
Jan-29-21 09:05PM  
Jan-28-21 04:10PM  
Jan-27-21 10:10AM  
Jan-22-21 08:00AM  
Jan-21-21 03:39PM  
Jan-20-21 02:46PM  
Jan-15-21 12:10PM  
Jan-14-21 08:15AM  
Jan-13-21 11:15AM  
Jan-12-21 11:41AM  
Jan-11-21 09:48AM  
Jan-08-21 09:47AM  
Jan-05-21 12:18PM  
Jan-04-21 09:26AM  
Jan-01-21 11:50AM  
Dec-30-20 11:40AM  
Dec-29-20 08:00AM  
Dec-28-20 04:10PM  
Dec-27-20 12:10PM  
Dec-24-20 02:47PM  
Dec-23-20 01:45PM  
Dec-22-20 04:15PM  
Dec-21-20 04:41PM  
Dec-19-20 07:00AM  
Dec-18-20 05:17PM  
Dec-16-20 11:50AM  
Dec-14-20 11:40AM  
Dec-11-20 08:20AM  
Dec-09-20 09:40AM  
Dec-08-20 07:03AM  
Dec-07-20 06:13PM  
Dec-03-20 11:30AM  
Nov-30-20 01:46PM  
Nov-25-20 01:36AM  
Nov-24-20 01:35PM  
Nov-23-20 11:38AM  
Nov-19-20 06:33PM  
Nov-18-20 09:12AM  
Nov-17-20 10:35AM  
Nov-12-20 09:33AM  
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TYLER BRIAN S.Chief Executive OfficerMar 15Option Exercise183.375,5111,010,55224,501Mar 16 04:40 PM
TYLER BRIAN S.Chief Executive OfficerMar 15Sale186.665,5111,028,68318,990Mar 16 04:40 PM
TYLER BRIAN S.Chief Executive OfficerFeb 16Option Exercise183.375,5101,010,36924,500Feb 17 05:27 PM
TYLER BRIAN S.Chief Executive OfficerFeb 16Sale183.385,5101,010,42418,990Feb 17 05:27 PM
Flores NancyEVP, CIO & CTOFeb 07Option Exercise0.005,43805,438Feb 09 06:54 PM
TYLER BRIAN S.Chief Executive OfficerJan 15Option Exercise183.375,5101,010,36924,500Jan 20 05:34 PM
Vitalone Britt J.EVP & CFOJan 15Option Exercise159.004,339689,9015,390Jan 20 05:37 PM
Vitalone Britt J.EVP & CFOJan 15Sale185.009,0571,675,5451,051Jan 20 05:37 PM
Reddy Sundeep G.SVP & ControllerJan 15Sale182.3245082,0441,534Jan 20 05:36 PM
TYLER BRIAN S.Chief Executive OfficerJan 15Sale184.325,5101,015,62418,990Jan 20 05:34 PM
Faber TracyEVP & Chief HR OfficerDec 15Sale174.0054695,0042,101Dec 16 07:08 PM
Vitalone Britt J.EVP & CFONov 04Option Exercise144.436,324913,37512,090Nov 05 05:18 PM
Faber TracyEVP & Chief HR OfficerNov 04Option Exercise0.0090102,710Nov 06 05:27 PM
Vitalone Britt J.EVP & CFONov 04Sale165.006,3241,043,4605,766Nov 05 05:18 PM
Vitalone Britt J.EVP & CFONov 03Option Exercise0.008,18109,229Nov 05 05:18 PM
Jacobs Christine MDirectorNov 03Sale160.001,157185,1200Nov 04 12:09 PM
COLES N ANTHONYDirectorAug 17Sale156.772,453384,5590Aug 19 03:35 PM
KNOWLES MARIE L/CADirectorAug 07Sale150.831,157174,5100Aug 10 05:39 PM
Vitalone Britt J.EVP & CFOJun 02Option Exercise144.436,324913,3757,372Jun 04 02:54 PM
Vitalone Britt J.EVP & CFOJun 02Sale158.906,3241,004,9091,048Jun 04 02:54 PM
Schechter Lori A.EVP, Chief Legal Officer & GCJun 01Option Exercise144.435,488792,63211,397Jun 02 07:04 PM
Schechter Lori A.EVP, Chief Legal Officer & GCJun 01Sale160.005,488878,0805,909Jun 02 07:04 PM
Faber TracyEVP & Chief HR OfficerMay 30Option Exercise0.001,15402,090Jun 02 07:03 PM
Reddy Sundeep G.SVP & ControllerMay 30Option Exercise0.0023102,153Jun 02 07:03 PM
Vitalone Britt J.EVP & CFOMay 27Sale149.601,034154,6861,048May 28 06:53 PM
Reddy Sundeep G.SVP & ControllerMay 27Sale149.609213,7631,922May 28 06:50 PM
Reddy Sundeep G.SVP & ControllerMay 26Sale152.45598,9951,955May 26 08:12 PM
Vitalone Britt J.EVP & CFOMay 23Option Exercise0.001,36702,415May 26 08:15 PM
Faber TracyEVP & Chief HR OfficerMay 23Option Exercise0.0085401,154May 26 08:14 PM
Reddy Sundeep G.SVP & ControllerMay 23Option Exercise0.0052402,172May 26 08:12 PM
Vitalone Britt J.EVP & CFOMay 22Sale145.912,358344,0561,048May 26 08:15 PM
Vitalone Britt J.EVP & CFOMay 21Option Exercise0.003,11704,165May 26 08:15 PM
Faber TracyEVP & Chief HR OfficerMay 21Option Exercise0.003840384May 26 08:14 PM
TYLER BRIAN S.Chief Executive OfficerMay 21Option Exercise0.0010,260022,452May 26 08:13 PM
Reddy Sundeep G.SVP & ControllerMay 21Option Exercise0.0033801,750May 26 08:12 PM
Schechter Lori A.EVP, Chief Legal Officer & GCMay 21Option Exercise0.002,70602,706May 26 08:11 PM
Reddy Sundeep G.SVP & ControllerMay 12Sale141.18618,6121,412May 13 03:42 PM
Reddy Sundeep G.SVP & ControllerMay 09Option Exercise0.0034901,580May 12 07:02 PM